Genzyme (GENZ) Confirms Issues Discussed in Presentation This Morning: $89/Share Estimate, Q4, FY11 Outlook

October 22, 2010 11:37 AM EDT Send to a Friend
Genzyme (Nasdaq: GENZ) has just issued a press release confirmed the topics that were disclosed during ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login